中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
27期
39-40
,共2页
晚期胃癌%化学治疗%含氟脲嘧定方案
晚期胃癌%化學治療%含氟脲嘧定方案
만기위암%화학치료%함불뇨밀정방안
Advanced gastric cancer%Chemotherapy regimen%Containing lfuorouracil scheme
目的:比较SC、XP、FOLFOX、CF、DCF等化疗方案治疗晚期胃癌的效果。方法回顾分析48例分别采用SC、XP、FOLFOX、CF及DCF多种治疗方案的初治晚期胃癌患者:采用方案根据患者的一般情况、经济条件或者患者从上级医院带来的方案。每28天为1个疗程,完成2个周期的化疗后,评估患者的近期疗效和毒副反应。结果含氟方案总的近期疗效54.1%。常见的不良反应为血液学毒性,恶心呕吐,肌肉酸痛,疲乏,脱发,患者均基本可耐受。结论晚期胃癌患者应用含氟方案近期疗效较好,不良反应可以耐受,值得临床参考。
目的:比較SC、XP、FOLFOX、CF、DCF等化療方案治療晚期胃癌的效果。方法迴顧分析48例分彆採用SC、XP、FOLFOX、CF及DCF多種治療方案的初治晚期胃癌患者:採用方案根據患者的一般情況、經濟條件或者患者從上級醫院帶來的方案。每28天為1箇療程,完成2箇週期的化療後,評估患者的近期療效和毒副反應。結果含氟方案總的近期療效54.1%。常見的不良反應為血液學毒性,噁心嘔吐,肌肉痠痛,疲乏,脫髮,患者均基本可耐受。結論晚期胃癌患者應用含氟方案近期療效較好,不良反應可以耐受,值得臨床參攷。
목적:비교SC、XP、FOLFOX、CF、DCF등화료방안치료만기위암적효과。방법회고분석48례분별채용SC、XP、FOLFOX、CF급DCF다충치료방안적초치만기위암환자:채용방안근거환자적일반정황、경제조건혹자환자종상급의원대래적방안。매28천위1개료정,완성2개주기적화료후,평고환자적근기료효화독부반응。결과함불방안총적근기료효54.1%。상견적불량반응위혈액학독성,악심구토,기육산통,피핍,탈발,환자균기본가내수。결론만기위암환자응용함불방안근기료효교호,불량반응가이내수,치득림상삼고。
Objective Comparing different chemotherapy regimen SC, XP, FOLFOX, CF, DCF model, such as chemotherapy regimens for the treatment of advanced gastric cancer. Methods Retrospective analysis of 48 cases with SC, XP, FOLFOX, CF and DCF model a variety of early treatment of patients with advanced gastric cancer:Using scheme according to the patient's general condition ,economic conditions or brought from the superior hospital patients with solution. The cycle of the chemotherapy was 28 days was given for 2cycles Evaluate the recent curative effect and adverse reaction of patients. Results The total effective rate (CR+PR) was 54.1%. Common adverse events were hematological toxicity, nausea, vomiting, muscle aches, fatigue, hair loss. The adverse reactions are well tolerated. Conclusion Containing lfuorouracil scheme chemotherapy for advanced gastric cancer can improve the curative effect, reduce the chemotherapy reaction, and improve the quality of life. Is worth for clinical reference.